Skip to content

DNA Supplier Ansa Biotechnologies Snares $68 Million

  • Published

“Venture capitalists have supplied $68 million in fresh capital to Ansa Biotechnologies Inc., a startup that says it has developed a new way to produce DNA needed to develop medicines and other products made through genetic engineering.”

”Emeryville, Calif.-based Ansa says it has technology for writing genetic code that relies on enzymes instead of chemicals that current vendors use. This will enable faster and more accurate production of genetic material, especially for long sequences of DNA, which will be vital as demand for genetic material expands, Ansa backers said.”

Read the full article.